Outcomes Remain Poor for Colorectal Cancer Patients with Brain Metastases
A retrospective cohort study investigated the incidence of and risk factors for brain metastases in patients with colorectal cancer.
Colorectal Cancer
Chemotherapy Associated With Reduced Risk of Alzheimer Disease in CRC Survivors
A retrospective study was conducted to identify the relationship between Alzheimer disease or other neurocognitive disorders and previous treatment with chemotherapy for colorectal cancer.
Colorectal Cancer: What Your Patients Need to Know
Although many Americans are at risk of developing colorectal cancer, they may not be aware of their own specific risk factors that they could have for it. What should medical professionals be teaching their patients about on regarding the risks, symptoms, detection, and prevention of colorectal cancer?
Review Shows Evidence of Link Between Diet, Colorectal Cancer Risk
A review of meta-analyses sought to grade the evidence related to associations between dietary factors and colorectal cancer risk.
Presence of Diabetes and Risks for Anemia, Infection in Colorectal Cancer Survivors
A retrospective study of electronic health records sought to determine the effect of presence of diabetes on long-term outcomes for colorectal cancer survivors.
Wearable Fitness Tracker Feasibly Quantifies Physical Activity in CRC
Patients with colorectal cancer (CRC) were prospectively enrolled into 2 cohorts and asked to wear a fitness tracker for 4 days at baseline and at follow-up.
Patient-Ordered Testing May Up CRC Screening Adherence
Patients self-ordering FIT tests for colorectal cancer screening through an electronic reminder more likely to complete a kit.
Retifanlimab Under Review for Anal Squamous Cell Carcinoma
The BLA is supported by data from the POD1UM-202 trial that evaluated retifanlimab in 94 adults with locally advanced or metastatic SCAC who progressed after platinum-based chemotherapy.
Retifanlimab Under Review for Anal Squamous Cell Carcinoma
The BLA is supported by data from the POD1UM-202 trial that evaluated retifanlimab in 94 adults with locally advanced or metastatic SCAC who progressed after platinum-based chemotherapy.
Lenvatinib Plus Pembrolizumab Safe, Effective in non-MSI-H/pMMR CRC
LEAP-005 investigators tested the safety and efficacy of combination lenvatinib and pembrolizumab in 32 patients with previously treated advanced non–microsatellite instability-high (MSI-H)/mismatch repair proficient (pMMR) colorectal cancer (CRC).
- Loading...
Loading...
Next post in Gastrointestinal Cancer
Loading... 
Loading...